Answers are grounded in this paper and cite their sources.
Context.— Virtual staining is a transformative artificial intelligence (AI)–driven approach in digital pathology that computationally synthesizes histologic and immunohistochemical stain appearances from unstained tissue or existing stained slides. By reducing dependence on chemical stains, virtual staining has the potential to improve turnaround time, while promoting tissue conservation and enhancing reproducibility. Recent advances in generative AI (GenAI) have substantially improved visual fidelity and structural preservation; however, clinical integration remains hindered by technical challenges in data acquisition, image co-registration, evaluation rigor, and multi-institutional generalizability. Objective.— To provide a comprehensive review of virtual staining in digital pathology, with particular emphasis on image co-registration, GenAI paradigms, evaluation methodologies, and emerging 2D and 3D workflows relevant to clinical laboratory practice. Data Sources.— A structured review of the literature was conducted, encompassing studies on label-free and stain-to-stain virtual staining, image co-registration techniques, various GenAI model architectures, multimodal approaches, evaluation strategies, and translational considerations in digital pathology. Conclusions.— Virtual staining represents a rapidly advancing domain with significant potential to augment pathology workflows and expand access to diagnostically relevant information, particularly when patient samples are limited. Accurate image co-registration remains a critical determinant of model fidelity in supervised pipelines, while existing evaluation practices often fail to capture pathology-specific diagnostic requirements. Emerging applications, including multiplex and 3D virtual staining, further emphasize the need for robust validation, standardized evaluation frameworks, and workflow-aware deployment strategies. Continued methodologic innovation, coupled with clinically grounded validation, will be essential for translating virtual staining from experimental feasibility to reliable clinical use.
No takes yet. Share an insight, caveat, or question.
Littlefield et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: